IRIX Form 4: CFO Romeo Dizon Buys 1,500 Shares Total
Rhea-AI Filing Summary
Romeo R. Dizon, Chief Financial Officer of IRIDEX Corp (IRIX), reported two open-market purchases of company common stock on 08/15/2025. He acquired 1,000 shares at $1.1799 per share and 500 shares at $1.15 per share, bringing his total reported beneficial ownership to 39,245 shares following the transactions. The Form 4 was signed on behalf of Mr. Dizon by an attorney-in-fact on 08/18/2025. No derivative transactions or other material changes were reported in this filing.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider purchases were disclosed but are small in absolute size and do not by themselves indicate material change.
The filing documents two non-derivative purchases by the issuer's CFO on 08/15/2025: 1,000 shares at $1.1799 and 500 shares at $1.15, increasing his reported beneficial ownership to 39,245 shares. These are routine Section 16 disclosures of open-market purchases. The transaction sizes and prices shown are explicit in the filing and there are no derivative positions or other arrangements disclosed. From a reporting perspective this is a standard Form 4 update and appears procedural rather than materially impactful to enterprise valuation.
TL;DR: The Form 4 properly reports insider purchases; filing includes signature by attorney-in-fact and lists officer title.
The document identifies Romeo R. Dizon as the reporting person and notes his role as Chief Financial Officer. It discloses two purchase transactions on 08/15/2025 and shows the required signature block executed by an attorney-in-fact on 08/18/2025. There are no amendments, no indication of Rule 10b5-1 plans, and no indirect ownership changes recorded. Procedurally, the filing meets Section 16 disclosure requirements based on the content provided.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 1,000 | $1.1799 | $1K |
| Purchase | Common Stock | 500 | $1.15 | $575.00 |
Footnotes (1)
FAQ
What transactions did IRIX insider Romeo R. Dizon report on Form 4?
What is Romeo R. Dizon's role at IRIDEX Corp (IRIX) as stated in the filing?
When were the transactions and the Form 4 signature dated?
Did the Form 4 report any derivative securities or Rule 10b5-1 plans?